rs7187438

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000548.5(TSC2):​c.1717-55T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.349 in 1,612,486 control chromosomes in the GnomAD database, including 103,676 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.42 ( 15472 hom., cov: 33)
Exomes 𝑓: 0.34 ( 88204 hom. )

Consequence

TSC2
NM_000548.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: -0.572

Publications

17 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 16-2070401-T-C is Benign according to our data. Variant chr16-2070401-T-C is described in ClinVar as Benign. ClinVar VariationId is 65157.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.665 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSC2NM_000548.5 linkc.1717-55T>C intron_variant Intron 16 of 41 ENST00000219476.9 NP_000539.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSC2ENST00000219476.9 linkc.1717-55T>C intron_variant Intron 16 of 41 5 NM_000548.5 ENSP00000219476.3

Frequencies

GnomAD3 genomes
AF:
0.423
AC:
64283
AN:
151948
Hom.:
15446
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.672
Gnomad AMI
AF:
0.457
Gnomad AMR
AF:
0.325
Gnomad ASJ
AF:
0.393
Gnomad EAS
AF:
0.237
Gnomad SAS
AF:
0.254
Gnomad FIN
AF:
0.298
Gnomad MID
AF:
0.434
Gnomad NFE
AF:
0.340
Gnomad OTH
AF:
0.440
GnomAD4 exome
AF:
0.341
AC:
497687
AN:
1460420
Hom.:
88204
AF XY:
0.338
AC XY:
245381
AN XY:
726492
show subpopulations
African (AFR)
AF:
0.693
AC:
23209
AN:
33472
American (AMR)
AF:
0.225
AC:
10074
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.396
AC:
10340
AN:
26130
East Asian (EAS)
AF:
0.263
AC:
10445
AN:
39688
South Asian (SAS)
AF:
0.265
AC:
22823
AN:
86238
European-Finnish (FIN)
AF:
0.288
AC:
15078
AN:
52276
Middle Eastern (MID)
AF:
0.441
AC:
2544
AN:
5764
European-Non Finnish (NFE)
AF:
0.343
AC:
381330
AN:
1111800
Other (OTH)
AF:
0.362
AC:
21844
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
21878
43756
65634
87512
109390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12208
24416
36624
48832
61040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.423
AC:
64348
AN:
152066
Hom.:
15472
Cov.:
33
AF XY:
0.417
AC XY:
31016
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.672
AC:
27849
AN:
41450
American (AMR)
AF:
0.325
AC:
4962
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.393
AC:
1364
AN:
3468
East Asian (EAS)
AF:
0.237
AC:
1228
AN:
5180
South Asian (SAS)
AF:
0.254
AC:
1226
AN:
4822
European-Finnish (FIN)
AF:
0.298
AC:
3158
AN:
10588
Middle Eastern (MID)
AF:
0.442
AC:
130
AN:
294
European-Non Finnish (NFE)
AF:
0.340
AC:
23095
AN:
67956
Other (OTH)
AF:
0.435
AC:
919
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1785
3570
5354
7139
8924
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
568
1136
1704
2272
2840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.379
Hom.:
16788
Bravo
AF:
0.442
Asia WGS
AF:
0.255
AC:
888
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 43% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 40. Only high quality variants are reported. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Jun 20, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Tuberous sclerosis 2 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tuberous sclerosis syndrome Other:1
-
Tuberous sclerosis database (TSC2)
Significance:not provided
Review Status:no classification provided
Collection Method:curation

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.2
DANN
Benign
0.27
PhyloP100
-0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7187438; hg19: chr16-2120402; COSMIC: COSV54767291; COSMIC: COSV54767291; API